Medicare Enrolled
Dr. Jeffrey Carr, MD
Interventional Cardiology · Tyler, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carr? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Carr
Dr. Jeffrey Carr is an interventional cardiology in Tyler, TX, with 20 years in practice. Based on federal Medicare data, Dr. Carr performed 2,017 Medicare services across 1,588 unique beneficiaries.
Between the years covered by Open Payments, Dr. Carr received a total of $2,003,630 from 60 pharmaceutical and/or device companies across 654 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Carr is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ 2,017 Medicare services$ $2,003,630 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,017
Medicare services
Bottom 46% in TX for interventional cardiology
1,588
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~101 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 494 | $6 | $19 |
| Hospital follow-up visit, moderate complexity | 170 | $61 | $184 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 156 | $17 | $97 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 135 | $25 | $146 |
| Office visit, established patient (30-39 min) | 121 | $71 | $341 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 112 | $430 | $4,322 |
| Electrocardiogram (EKG), 12-lead | 106 | $8 | $56 |
| Hospital follow-up visit, high complexity | 80 | $93 | $269 |
| Office visit, established patient, complex (40-54 min) | 63 | $116 | $450 |
| Initial hospital admission, high complexity | 43 | $119 | $546 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 41 | $15 | $57 |
| Ultrasound of leg arteries or artery grafts | 41 | $29 | $177 |
| New patient office visit, complex (60-74 min) | 39 | $134 | $592 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $14 | $221 |
| Ultrasound of heart, follow-up | 31 | $18 | $316 |
| Initial hospital admission, moderate complexity | 30 | $102 | $339 |
| Ultrasonic guidance for blood vessel access | 28 | $13 | $392 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 28 | $20 | $67 |
| Echocardiogram, transthoracic | 28 | $53 | $679 |
| Ultrasound study of arm and leg arteries | 26 | $9 | $158 |
| Injection of chemical agent into single incompetent vein | 23 | $31 | $444 |
| Ultrasound of both sides of head and neck blood flow | 22 | $28 | $162 |
| New patient office visit (45-59 min) | 19 | $94 | $394 |
| Review by radiologist of both arms or legs arteries image | 18 | $69 | $2,155 |
| Programming of dual lead pacemaker system | 18 | $29 | $200 |
| Critical care, first 30-74 min | 16 | $149 | $694 |
| Review by radiologist of abdominal aorta image | 15 | $49 | $2,465 |
| Coronary stent placement | 15 | $416 | $1,938 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $2 | $29 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 13 | $500 | $2,190 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $83 | $812 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $14 | $158 |
| Cardiac catheterization | 11 | $152 | $3,680 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.5% high complexity
29.7% medium
64.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,003,630
Total received (2018-2024)
Avg $286,233/year across 7 years
Top 0% in TX for interventional cardiology
60
Companies
654
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$1,491,190 (74.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$252,018 (12.6%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$200,084 (10.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50,261 (2.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,078 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$23,770
2023$72,927
2022$68,301
2021$1,515,800
2020$66,650
2019$123,104
2018$133,079
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bard Peripheral Vascular, Inc.
$1,612,951
Medtronic Vascular, Inc.
$144,108
Venclose Inc.
$96,099
Philips Electronics North America Corporation
$66,858
Medtronic, Inc.
$36,991
Abbott Laboratories
$21,774
W. L. Gore & Associates, Inc.
$4,565
Cardiovascular Systems Inc.
$4,023
Boston Scientific Corporation
$3,541
CORDIS US CORP.
$2,410
Intact Vascular, Inc.
$2,094
Philips North America LLC
$1,200
Avinger Inc.
$1,046
Janssen Pharmaceuticals, Inc
$747
Novartis Pharmaceuticals Corporation
$534
AngioDynamics, Inc.
$447
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$339
BOSTON SCIENTIFIC CORPORATION
$335
Gilead Sciences, Inc.
$293
BIOTRONIK INC.
$270
Merck Sharp & Dohme LLC
$219
E.R. Squibb & Sons, L.L.C.
$210
Amgen Inc.
$181
HeartFlow, Inc.
$170
ShockWave Medical, Inc
$168
Vasorum USA Inc.
$138
Penumbra, Inc.
$136
Ablative Solutions, Inc.
$134
ABIOMED
$122
Merck Sharp & Dohme Corporation
$103
Endologix LLC
$99
AstraZeneca Pharmaceuticals LP
$98
Reflow Medical Inc
$97
SANOFI-AVENTIS U.S. LLC
$96
CARDIVA MEDICAL, INC.
$92
Novo Nordisk Inc
$91
Astellas Pharma US Inc
$82
Alnylam Pharmaceuticals Inc.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
AtriCure, Inc.
$69
Regeneron Healthcare Solutions, Inc.
$61
CVRx, Inc.
$55
Edwards Lifesciences Corporation
$49
HEARTFLOW, INC.
$32
InspireMD Ltd
$31
iRhythm Technologies, Inc.
$31
Veryan Medical Incorporated
$30
Siemens Medical Solutions USA, Inc.
$28
Lundbeck LLC
$27
ACIST MEDICAL SYSTEMS, INC.
$24
PFIZER INC.
$24
Esperion Therapeutics, Inc.
$23
Cardinal Health 200 LLC
$23
BARD PERIPHERAL VASCULAR, INC.
$23
Becton, Dickinson and Company
$21
Kiniksa Pharmaceuticals International, plc
$16
ASAHI INTECC USA, INC.
$15
CMP Pharma, Inc.
$14
Amarin Pharma Inc.
$14
Biocompatibles, Inc.
$12
Top 3 companies account for 92.5% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (6554) Peripheral Vascular Undivided · (6574) Coronary Other · (6577) Visions 014 · (7882) Image Guided Therapy Und · (8334) IGT D Peripheral · (8334) IGT_D Peripheral · (9520) IGT Devices Undivided · ABRE · ALPHAVAC · ARTIS icono biplane · ASAHI PTCA Guide Wire · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · Arcalyst · Artis icono floor · Asahi Fielder XT cornary guide wire · Asahi Fielder coronary guide wire · BRILINTA · BRITE TIP · Barostim Neo System · BioMimics · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CAROSPIR · CELT ACD · CGuard · CHANTIX · COREVALVE EVOLUT R · CVI SYSTEMS · CVX-300 · ClosureFast · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · Diamondback Peripheral · ELCA · ELIQUIS · ELLIPSYS VASCULAR ACCESS SYSTEM · ENDOCROSS Device · ENTRESTO · ESPRIT · EkoSonic · Endurant · FARXIGA · FFRct · FLOWMET · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL ATHERECTOMY · General - Vascular Intervention · HAWKONE · HawkOne · ICDs · IGT D Coronary · IGT D Peripheral · IGT D Service Syst · IGT Und · IGT Undivided · IGT_D Peripheral · IGT_D Systems · IGT_D Therapy · IN.PACT ADMIRAL · IN.PACT Admiral · IVUS Systems · Image Guided Therapy Devices _ Coronary · Image Guided Therapy Devices _ Therapy · Impella · JARDIANCE · LEQVIO · LEXISCAN · LUTONIX · LifeVest · Lutonix Drug Coated Balloon · MULTAQ · NEXLETOL · NORTHERA · OMNILINK ELITE · ONPATTRO · ONYX FRONTIER · Omnilink Elite vascular stent system · PANTHERIS · PRALUENT ALIROCUMAB INJECTION · Passeo-18 · Penumbra System · Perclose ProGlide suture mediated closure system · Product in Development · Pulsar-18 T3 · Repatha · Resolute · Rybelsus · S.M.A.R.T. CONTROL · SELUTION SLRPTA · SELUTION SLRPTCA · SUPERA · SYMPLICITY G3 · SYNERGY · SYNERGY ABLATION SYSTEM · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Spectranetics Undiv · Supera peripheral stent system · TURBOHAWK · Tack Endovascular System · TrailBlazer · Trilogy 100 · TurboHawk · VARITHENA · VENOVO · VERQUVO · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VIABAHN VBX Balloon Expandable Endoprosthesis · VIVA XT CRT-D · Varithena Administration Pack · Vascepa · VenaSeal · Venclose · Venclose Maven Catheter · Venovo · XARELTO · Xience Alpine cornary stent system · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 0% for interventional cardiology in TX.
Equivalent to $99,337 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
5
Per 100K population
2.1
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Carr is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 0%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Carr experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Carr performed 494 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carr receive payments from pharmaceutical companies?
Yes. Dr. Carr received a total of $2,003,630 from 60 companies across 654 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carr's costs compare to other interventional cardiologys in Tyler?
Dr. Carr's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Tyler
Browse interventional cardiologys in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc..
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Venclose Inc. Payments to Doctors
See all physicians who received payments from Venclose Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology